Due to rising antimicrobial resistance, the treatment of complicated UTIs and acute pyelonephritis is becoming more difficult ...

Innoviva’s zoliflodacin is a first-in-class, single-dose, oral spiropyrimidinetrione antibiotic currently under regulatory ...

Results from the QWINT-1 and QWINT-3 trials found that insulin-naïve patients achieved similar reductions in A1C levels using once-weekly efsitora compared to daily insulin glargine and degludec. Eli ...

Kodiak Sciences Inc said on Wednesday results from a mid-to-late stage trial failed to show non-inferiority of its experimental eye drug KSI-301 compared to Regeneron Pharmaceuticals' Eylea. The views ...

SUZHOU, China, Nov 18, 2024 /PRNewswire/ -- TenNor Therapeutics, a clinical-stage company dedicated to developing novel therapies to address unmet needs in infectious diseases, announced today the ...

JCO Precision Oncology Conversations features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they ...

−5.8 from baseline of 17.8 −6.9 from baseline of 18.5 −3.4 from baseline of 18.9 Pitolisant versus placebo (superiority test); mean difference: −3.0 (95% CI −5.6 to −0.4), p=0.024 Pitolisant versus ...